reported previously. 20-24 They were routinely maintained in
Introduction monthly for, and were consistently free from microbiological infections. Using HIV-1 IIIB virus inocula as previously Progressive depletion of CD4 + T cells in the peripheral blood described, 20 five other CD8 + HIV-1 carrier clones in addition is a consistent hematologic manifestation in HIV-1 infection. 1 to HPB-ALL/HIV, MOLT-4/HTLV III and SKW-3/HTLV III, 20 Dynamic turnover rates of CD4 + T cells and viral RNA in the were established from HPB-ALL, MOLT-4 and SUP-T1. Each peripheral blood have, however, been documented in patients HIV-1 carrier clone was judged to be a single clone on the infected with HIV-1.
2,3 Substantial evidence [4] [5] [6] [7] indicates, in basis of stable characteristics as determined by biological, fact, that viral activity and the activated cellular responses to immunophenotypical and virological parameters. 20 All thymoit are all high at primary sites of HIV-associated pathogenesis, cyte specimens were obtained from corrective cardiac surgery such as the lymph nodes (LN), even during early clinically (S Subramanian, Children's Hospital of Buffalo, Buffalo, NY, asymptomatic periods. Furthermore, thymocytes 8 and bone USA). The cryopreserved thymocytes were thawed, and dead marrow cells, 9 crucial for continued renewal of a mature lymcells were removed by Ficoll-Hypaque density gradient cenphocyte pool, are known to be susceptible to HIV-1 infection.
trifugation. Only thymocyte samples with good viability Indeed, in SCID-hu mouse studies, [10] [11] [12] [13] [14] HIV-1 infection was (Ͼ95%) were used. Portions of each sample were used for the shown to cause drastic destruction of grafted human thy-CT assay, and to determine antigen (Ag) profiles and proliferatmuses. In addition to the cytopathic loss of mature CD4 + T ive potential by 3 H-thymidine incorporation assay. All normal lymphocytes by virus replication in them, evidence has peripheral blood mononuclear cells (PBMC) were prepared accumulated indicating direct and/or indirect killing mechfrom volunteers with no known diseases. The PBMC thus anisms of uninfected CD4 + lymphocytes. [15] [16] [17] [18] [19] obtained was divided into two portions for immediate use and Using a panel of HIV-1 carrier cell clones reported earlier, 20 for use after mitogen (PHA, 10 g/ml; Sigma Chemicals, St a total of 12 HIV-1 carrier clones derived from either CD4CD8 Louis, MO, USA) stimulation in a 2-day culture. Portions of double-positive (DP) or CD4 single-positive (SP) parental leueach sample were used for the CT assay, and to determine Ag kemia clones, were examined to determine whether they have profiles and proliferative potential. any function associated with the HIV-1 carrier state. 20 It was found unexpectedly that within 1 h at 37°C, six of the 12 HIV-1 carriers, when they were combined with target uninfected Immunofluorescence analyses of virally and cellularly leukemia cell lines, were found to be cytotoxic (CT), causing coded characteristics a rapid target cell death in seven of the 10 thymic DP and/or SP leukemia cell lines, but not in any of the more mature DP Immunofluorescence analysis of cell surface and intracellular and/or SP leukemia cell lines. Furthermore, this novel cytoAg expression was performed by flow cytometry and fluordestruction of DP/SP thymic-leukemia cell lines by HIV-1 carescent microscopy using a panel of monoclonal and polyrier clones was demonstrated in the DP-dominant normaloto, Japan), by a human anti-HIV-1 gp120 mAb with CD4
found to be independent of this rapid cytotoxic reaction. CT scores of у2.0 were arbitrarily considered cytotoxic for effecbinding site specificity, b 12 (DR Burton, Scripps Research Institute, La Jolla, CA, USA) 25 or by AIDS patients' sera with tor activity and susceptible for target sensitivity. high Ab titers for p24, gp41, and gp120/gp160 (Y Yamamura of the AIDS Program of Ponce Medical School, Ponce, Puerto Rico).
Blocking test for CT reaction
In order to further characterize the CT reaction, experiments were carried out to block the relevant surface Ag expression, Assays for HIV-1 infectivity and HIV-1 p24 for example, CD4, CD8, major hisotocompatibility antigen complex class I (MHC-I), or HIV-1 Ags, by respective Abs on The HIV-1 infectivity assay was done by tissue culture ID 50 effectors (cytotoxic HIV-1 carriers), targets (susceptible DP (TCID 50 ) method with MT-2 cells as described earlier. 20 The thymic cell clones), or both prior to the CT assay. Briefly, p24 production levels of the cells were measured using an respective Ag expression of effector alone or target alone was ELISA kit (HIV Ag-1 monoclonal; Abbott Diagnostic Division, blocked individually by incubating the cells with FITC-labeled North Chicago, IL, USA). Cell-free virus per milliliter in a 2-Ab (at the concentration 40 times higher than the titer) for 60 day culture and cell-associated virus per 10 6 cells were used min followed by washing thoroughly to remove unbound to express the virally coded cellular characteristics of each excess Ab, prior to combining them for CT assay. 27 The modified flow cytometric PIexpression of a particular Ag singularly either on the target or CT assay using live cells allowed us to analyze the dynamics on the effector (prelabeled target or effector) before combining of the cytotoxic reaction closely. 28 For convenience, HIV-1 them for the two-color flow cytometric PI-CT analysis allowed carrier clones are referred to as the 'effector', and the uninus simultaneously not only to quantitate the percentage of PIfected CD4
+ CD8 + and/or CD4 + cell populations to be comstained dead cells by red fluorescence, but also to determine bined with them are referred to as the 'target'. In preliminary by green fluorescence (FITC) whether the pre-labeled target studies (data not shown) with an effector:target (E:T) ratio from and/or effector cells had died by the 1-h CT reaction. Various 0.2:1.0 to 1.0:0.2, we found no essential differences in the effector-target combinations were evaluated for changes or specificity of the cytotoxic reaction. Kinetic analysis of the differences in CT scores and for any possible FITC pre-labeled reaction up to 5 h showed that it took place so quickly that population shift resulting from Ag blockage. A difference in the maximal level was achieved in the first hour and then CT score of Ͼ2.0 between blocked and control CT tests was began tapering off. This was usually accompanied by the forarbitrarily considered significant. mation of varying sizes of syncytia and by a progressive loss of disintegrating dead cells making quantitative measurement of CT reaction unreliable. For this reason, a 1-h PI-CT assay Apoptosis analysis by electrophoretic and in situ (E:T ratio of 1:1) was used throughout the present study. Each cytochemical DNA fragmentation assays cell suspension of effector or target (viability Ͼ95%) was adjusted to 3 × 10 6 cells/ml in RPMI 1640 medium containing DNA from each sample (at least 5 × 10 6 cells) was extracted 5% FCS. The effector and target were combined (0.2 ml each), using an IsoQuick nucleic acid extraction kit (MicroProbe centrifuged for 2 min at 1000 r.p.m., and then the cell pellets Corp, Garden Grove, CA, USA), as described by the manufacwere incubated at 37°C for 1 h. The cell pellets were then turer. Briefly, 10 g of DNA for each sample was incubated dispersed completely, 50 l of 0.05% PI solution was added with 1 l of RNase (10 mg/ml) for 1 h at 37°C, mixed with to each sample, and the percentage of PI-stained dead cells 10 l of 10 mM EDTA containing 0.1% bromophenol blue and was determined immediately by flow cytometry (EPICS-PRO-25% Ficoll, and loaded into the wells of a 1.2% agarose gel. FILE II; Coulter Electronics, Hialeah, FL, USA) with a program Electrophoresis was carried out in TAE buffer (0.04 M Trisfor two-color analysis. No gating was used for the flow cytoacetate, 0.001 M EDTA), and the DNA was visualized by ethimetric PI-CT analysis. The results were expressed as CT scores dium bromide staining under UV illumination. 29 In situ cytowhich were a function of the percentage of PI-stained dead chemical DNA fragmentation analysis was carried out using cells in the test sample divided by half the sum of the percenta MEBSTAIN Apoptosis kit (TdT-mediated dUTP nick-end age of PI-stained effector alone and that of the target alone, labeling, TUNEL method) (Medical and Biological Laboraas shown in the following formula.
tories Co, Nagoya, Japan). 30 Briefly, each cytospin cell preparation was air-dried and fixed with 4% paraformaldehyde for CT score = % PI-test sample 1/2 (% PI-effector alone + % PI-target alone)
. 15 min at 4°C. The cells were then washed three times with distilled water, followed by a 10-min 0.5% Triton 100 treatment for permeabilization. The TdT reaction was carried out Following flow cytometry, morphological observation including HIV-1-induced syncytium formation in each test sample essentially as recommended by the manufacturer in the presence of biotin-dUTP. Avidin-conjugated fluorescein isothiocywas carried out under a microscope at ×200-400 magnification. Syncytium formation in the test sample was, however, anate was then used to detect the biotin-dUTP incorporated onto the DNA ends. Statistical analysis (monocytic) cell types, were tested for rapid and direct target cell destruction (Table 1) . Inappropriate combinations, such as Paired and unpaired data on antigen expression, CT tests, blocking experiments and TUNEL tests were analyzed by a cytotoxic effector and a nonsusceptible target or two different cytotoxic effectors, resulted in a CT score of less than 2.0 Student's t-test with P values of Ͻ0.05 being considered significant.
(mean CT score 1.3 ± s.e. 0.1 from 36 tests). Using a DP thymic T cell leukemia line (HPB-ALL) as a target, six of 12 HIV-1 carrier clones (consisting of five of nine CD8 + -and one CD8
− -HIV-1 carrier clones) were determined to be cytotoxic, Results but using another DP thymic leukemia cell line (SUP-T1) as a target, only one CD8 + -HIV-1 carrier clone was determined Cytotoxic reaction to clonal leukemia cell lines to be cytotoxic ( Table 1) . Expression of CD1, CD2, CD3, CD5, CD7, CD8, CD13, CD14, CD15, CD29, CD33, CD34, CD38, First, a panel of HIV-1 carrier clones and their parental cell lines were used, with both representing individual clonal CD45RA, CD45RO, CD58, CD95, TCR␣␤ or TCR␥␦, MHC classes I and II (MHC-I and -II), and cytoplasmic HIV-1 p24 populations. [20] [21] [22] [23] [24] It was found that some HIV-1 carriers (effectors), notably CD8 SP carriers, exhibited, within 1 h, CT was found to vary, indicating no specific correlation between the differentiation stage of the HIV-1 carrier clones and the activity to, and syncytium formation of, some T cell lines (targets) having a TdT + CD4CD8 DP and/or TdT + CD4 SP thydegree of their CT activity (data not all shown). Expression of membrane-bound HIV-1 gp120/gp160 in the carrier clones, mic phenotype ( Figure 1 and Table 1 ). Rapid CT reaction was not observed in any of the other 60 target cell lines with varihowever, correlated partially with CT activity (Table 1) . Nevertheless, each clone consistently expressed a particular ous phenotypes including more mature CD4 + CD8 + and/or set of these antigens as its own clonal characteristics.
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blocking test representative of at least four similar tests. Blocking CD8 or MHC-I expression on the effector or on the target, Neither the amount of persistent infectious virus production nor the amount of viral p24 production by each clone resulted in only an insignificant change or a slight increase in the CT scores. Both the FITC-prelabeled effector, showing a accounted for the CT activity (data not shown).
As for susceptible target cell lines, using highly cytotoxic peak on the histogram corresponding to Ͼ50% of the test population in the effector-target combination ( Figure 2B 21-24 were found to be susceptible. Using weakly cytotoxic MOLT-4/HIV C3 as an effector, however, arily by contact with the effector in this reaction, indicating unidirectional target destruction. only one early thymic-stage leukemia cell line (HPB-ALL) was found to be susceptible (Table 2) . While neither CD95 (Fas The results thus indicate that 50-90% (2 × the percentage of PI-stained dead cells in the 'E' + 'T' column in Figure 2B , antigen) expression nor the expression of other individual T cell-associated Ags was found to be associated with target cell C, E, and F) of the target cell population died in 1 h in this 1:1 E:T CT reaction. Blocking HIV-1 gp120/gp160 expression susceptibility (data not shown), expression of membranebound CD4 was, however, partially correlated with target suson the effector, or CD4 on the target, on the other hand, resulted in significantly reduced CT scores ( Figure 2D and G). ceptibility. Although the expression of all other T cell, myeloid cell, TCR and MHC Ags varied irrespective of their susceptiAs shown in Figure 2J , the combination between the HIV-1 gp120/gp160-blocked effector and the CD4-blocked target bility to CT activity, each cell line consistently expressed a particular set of these antigens as its own clonal characterresulted in complete inhibition of the CT reaction with a CT score of 1.3, similar to the negative CT control level. Howistics. 21 -24 It appears that targets from the earlier intrathymic differentiation stages, such as the TdT +
CD4
+ CD8 + and/or ever, in other combinations such as those shown in Figure 2H and I, there was no effect on the CT reaction. TdT +
+ phenotype, are readily susceptible to this CT activity, provided that the level of CD4 expression is signifi-
The results thus indicate clearly that while no significant involvement of CD8 or MHC-I expression was shown, the cant (Table 2) .
respective cell surface membrane expression of the HIV-1 Ags (gp120/gp160) on effectors and of the CD4 Ags on the thymic T cell targets (but not on mature T cell targets) is essentially
Further defining the cytotoxic reaction required for this unique CT reaction. One of the most crucial variables for this phenomenon appears to be the individual In order to further characterize the CT reaction, experiments were carried out to block the relevant surface Ag expression, clonal characteristics of the CT-susceptible targets which are strictly limited to the T-II and T-III stages 21,22 of T cell matufor example, MHC-I, CD8, CD4 and HIV-1 Ags, by respective antibodies on cytotoxic HIV-1 effectors and susceptible DP ration (TdT + D4 + CD8 + or TdT Table 2) , although presentation of membrane-bound gp120/gp160 by the effectors is thymic cell targets prior to CT reaction at a 1:1 E:T ratio as detailed in the Materials and methods. Figure 2 illustrates the undoubtedly another essential requirement (Table 1 and Figure 2 ). Thus, it is quite clear that each antigen must be results of the flow cytometric PI-CT analysis from an antigen Cytotoxic reaction against normal thymocytes taining both mature SP CD4 and mature SP CD8 T cells were susceptible to the CT activity of the HIV-1 carrier clones The unique CT reaction demonstrating a particular interaction between immature T cells and HIV-1-infected T cells using a (Table 3) . leukemia cell line panel, prompted us to examine the normal in vivo counterpart which consists mainly of DP cells and is Absence of apoptotic DNA fragmentation in the a TdT + DP and/or TdT + SP rich thymocyte population. Thus, we cytotoxic reaction next studied thumocytes and found that they were equally susceptible to the CT activity of the HIV-1 carrier clones (Table 3 , Due to the possibility that the target thymic cell death by con- Figure 1c and d, and Figure 3 ). As summarized in Table 3, CT tact with the HIV-1 carriers shown in the present study could reactions using CD8
+ HIV-1 carrier clones such as HPBbe apoptotic cell death, DNA fragmentation analysis was per-ALL/HIV, MOLT-4/HIV C3 and MOLT-4/HIV C9 consistently formed by two methods. As shown in Figure 4 , there were resulted in target thymocyte death in all 15 cases. Most of some samples with DNA ladder formation irrespective of the the noncytotoxic HIV-1 T cell carrier clones turned out to be CT reaction and of cell sample. As predicted, both the PHAcytotoxic to target thymocytes (Table 3 and Figure 3C ) unlike induced PBMC alone and in combination with an effector, or the case of the leukemia cell line targets. It is noteworthy, in the combination of thymocytes and effector, demonstrated however, that thymocytes remained non-susceptible to CD8 + apoptotic DNA fragmentation which is known to be present SKW-3/HTLV III, but that they were moderately susceptible to as an inherent process in actively proliferating hematopoietic CD8 − HL-60/HIV (Table 3 and Figure 3D and E), albeit sigcells. Similarly, by in situ DNA fragmentation analysis (TUNEL nificantly less so than to other cytotoxic CD8 + HIV-1 carriers test) there was no positive correlation of the TUNEL reaction (P Ͻ 0.05) ( Table 3) .
(2.8 ± 0.1% in six TUNEL tests) with this rapid thymic cell A portion of each sample was used to determine antigen death. For a positive apoptosis control, PHA-stimulated profiles and proliferative potential by 3 H-thymidine incorpor-MOLT-16 (a TCR␣␤ + TdT + CD4 − CD8 − T cell leukemia line) ation assay. The ranges of antigen expression in thymocytes clearly demonstrated DNA fragmentation by both methods as determined by fluorescent microscopy were: TdT, 95-99%; (Figure 4 , and 67 ± 12% in three TUNEL tests). CD1, 93-99%; CD3, 44-99%; CD4, 85-99%; CD8, 80-99%; MHC-I, 95-99%; MHC-II, 0-5%. The proliferative potential of normal thymocytes as determined in a 1-day culture of 1 × 10 6 Discussion cells/ml using RPMI medium supplemented with 10% pooled human sera by 3 H-thymidine incorporation assay was While CD4 + T cell depletion in the blood during the course of HIV-1 infection is a hallmark of this disease, the pathogenesis 58 056 ± 13 938 d.p.m. (mean ± s.e.), indicating actively pro- 
Table 3
Susceptibility 
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activation and apoptosis of diverse T cell subsets. 1, [4] [5] [6] [7] 19 The present finding, however, does not necessarily conflict with those reports dealing mainly with activated but mature T cells, because the susceptible target thymic cells in our study represent an immature stage of T cell differentiation. Alternatively, it is conceivable that the uninfected 'bystander' CD4 + T cell apoptosis in the HIV-1-infected LN as recently reported 19 can be killed directly and specifically, without virus infection, by mechanisms similar to those of the cytotoxic HIV-1-infected CD4 + T cells in the blood as recently reported. [15] [16] [17] [18] In HIV-1 infection, blood CD8
+ cells are generally considered to be beneficial for the patient because high CD8 + cell counts in the blood are associated with the long-term stability of the patient [35] [36] [37] and because the peripheral blood CD8 + T cells of HIV-1 seropositive individuals exhibit specific MHCrestricted CTL activity. [38] [39] [40] It was shown, however, that under certain circumstances, CD8
+ T cells can harbor the virus and in turn may facilitate the spreading and latency of HIV-1 infection. 41 Indeed, the CD8 + T cells in bronchoalveolar lavages from AIDS patients were shown to have integrated and functional HIV-1 DNA in all four cases examined. 42 Quite recently, the fact that HIV-1-infected peripheral blood CD8 + cells were frequently found, 43 is consistent with what we dealt with the CD8 + HIV-1 carriers. In view of findings demonstrating extremely high turnover rates of CD4 + T cells and viral ceptible to direct killing by HIV-1 infected cells in a non-MHC-restricted manner, [15] [16] [17] [18] and to the drastic and rapid depletion of the grafted thymus tissue associated with HIV-1 responsible for this depletion has not been fully elucidated.
As an in vitro model experiment, we have observed a novel infection in all thymocyte subsets in SCID-hu models. [10] [11] [12] [13] [14] These accumulated findings could conceivably be related to rapid thymic cell death phenomenon without MHC restriction to, or virus replication in, the targets by contact with some the in vitro rapid thymic cell death phenomenon we observed, and indeed they are all relevant to the better understanding HIV-1 carrier clones (notably CD8 + clones) specific to TdT + CD4 + CD8 + and/or TdT + CD4 + thymic T cell targets, of HIV-1 pathogenesis. The present in vitro study, nonetheless, demonstrates clearly including an autologous combination of parental DP cells (HPB-ALL) and their CD8 SP HIV-1 carrier progeny clones that at the clonal level, HIV-1 carrier T cell clones, which are likely present in vivo, 8, [41] [42] [43] [44] are responsible for the profound (HPB-ALL/HIV and HPB-ALL/HIV C1) (Tables 1 and 2 ). The results of the present study indicated clearly that CD4 death of intact DP thymocytes in a non-MHC-restricted manner. Indeed, HIV-1 infection in the thymus organ culture study expression specifically on the targets, and HIV-1 gp120/gp160 specifically on the effectors, were essential for rapid target reported clearly indicated a preferential and progressive loss of CD4 + thymic cells leaving a relative increase of CD8 + thydeath as demonstrated using clonal cell populations ( Figure 2D, G and J) . The thymocyte death phenomenon we mic cells. 45 HIV-1 infection in the thymus and/or equivalent lymphopoietic tissue sites may lead to a complex paradoxical observed may indeed mimic the immunological selection process of differentiating immature CD4 + CD8 + thymocytes by and dynamic virus-to-cell interaction. Thus the in vitro study described here suggests a novel rationale for the progressive means of the programed cell death referred to as apoptosis. 27, 28, [30] [31] [32] However, neither typical apoptosisdepletion of peripheral blood CD4 + T cells in HIV-1 infection. associated DNA ladder formation nor the in situ TUNEL reaction were found in the rapid thymic cell death phenomenon we observed (Figure 4 ). 
